Results 251 to 260 of about 1,148,410 (327)

AI in Combating Cyber Threats to Indian Pharmaceutical Intellectual Property: Legal Perspectives.

J Pharm Bioallied Sci
Sharma G, Variath AG, Medhoo P, Srivastava A, Rathore S, Rathore D.   +5 more
europepmc   +1 more source

Monoclonal antibody formulations: a quantitative analysis of marketed products and patents. [PDF]

MAbs
Peng Y, Lyu L, Chen S, Ning B, Li C, Wu CY, Hu Y.   +6 more
europepmc   +1 more source

Dollars and dilemmas: lenacapavir's pricing, patents, and the path to affordability. [PDF]

Int J Equity Health
Adepoju VA, Abdulrahim A.
europepmc   +1 more source

Equitable access to costly new drugs.

BMJ
Woods B, Ten Ham R, Claxton K.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmaceutical patents

Research Handbook on Patent Law and Theory, 2019
John R. Thomas
semanticscholar   +2 more sources

Pharmaceutical Patents

SSRN Electronic Journal
Charisis Panagiotis Ziogas
semanticscholar   +2 more sources

Pharmaceutical Patents and Evergreening

SSRN Electronic Journal, 2021
H. Moir
semanticscholar   +2 more sources

Replace Pharmaceutical Patents Now

PharmacoEconomics, 2012
Pharmaceutical patents are anachronistic holdovers from an era in which modern economic understanding and tax tools were unavailable. Superior mechanisms lie somewhere between a first best pricing solution for the entire economy at one extreme and the current arrangements at the other. We discuss the economics of suggested alternatives and suggest that
E. Grinols, J. W. Henderson
semanticscholar   +3 more sources